Literature DB >> 19730767

Embolization of uterine arteriovenous malformations associated with cyanotic congenital heart disease.

N T Wijesekera1, S P Padley, F Kazmi, C L Davies, J M McCall.   

Abstract

Uterine arteriovenous malformation (AVM) is a rare cause of vaginal bleeding and miscarriage. We report two cases of uterine AVMs in patients with a history of complex congenital heart disease, an association that has not been previously described. Both patients were treated by selective uterine artery embolization, a minimally invasive therapy that has revolutionized the management of uterine AVMs, thus offering an alternative to conventional hysterectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19730767     DOI: 10.1007/s00270-009-9573-z

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Conservative therapy with a gonadotropin-releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease.

Authors:  Kinue Katano; Yutaka Takeda; Mayumi Sugiura-Ogasawara
Journal:  Clin Case Rep       Date:  2015-04-29

2.  Arteriovenous malformation of the uterus.

Authors:  Nazera Dodia; Suku George
Journal:  BMJ Case Rep       Date:  2015-09-17

3.  A Systematic Review of Acquired Uterine Arteriovenous Malformations: Pathophysiology, Diagnosis, and Transcatheter Treatment.

Authors:  Daniel J Yoon; Megan Jones; Jamal Al Taani; Catalin Buhimschi; Joshua D Dowell
Journal:  AJP Rep       Date:  2015-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.